TLR stimulation modifies BLyS receptor expression in follicular and marginal zone B cells. 2007

Laura S Treml, and Gianluca Carlesso, and Kristen L Hoek, and Jason E Stadanlick, and Taku Kambayashi, and Richard J Bram, and Michael P Cancro, and Wasif N Khan
Department of Pathology and Laboratory Medicine, University of Pennsylvania School of Medicine, 36th and Hamilton Walk, Philadelphia, PA 19104, USA.

Through their differential interactions with B lymphocyte stimulator (BLyS) and a proliferation-inducing ligand (APRIL), the three BLyS family receptors play central roles in B cell survival and differentiation. Recent evidence indicates BLyS receptor levels shift following BCR ligation, suggesting that activation cues can alter overall BLyS receptor profiles and thus ligand sensitivity. In this study, we show that TLR stimuli also alter BLyS receptor expression, but in contrast to BCR ligation, TLR9 and TLR4 signals, preferentially increase transmembrane activator calcium modulator and cyclophilin ligand interactor (TACI) expression. Although both of these TLRs act through MyD88-dependent mechanisms to increase TACI expression, they differ in terms of their downstream mediators and the B cell subset affected. Surprisingly, only TLR4 relies on c-Rel and p50 to augment TACI expression, whereas TLR9 does not. Furthermore, although all follicular and marginal zone B cells up-regulate TACI in response to TLR9 stimulation, only marginal zone B cells and a subset of follicular B cells respond to TLR4. Finally, we find that both BLyS and APRIL enhance viability among quiescent and BCR-stimulated B cells. However, although BLyS enhances viability among TLR stimulated B cells, APRIL does not, suggesting that TACI but not BLyS receptor 3 may share survival promoting pathways with TLRs.

UI MeSH Term Description Entries
D008070 Lipopolysaccharides Lipid-containing polysaccharides which are endotoxins and important group-specific antigens. They are often derived from the cell wall of gram-negative bacteria and induce immunoglobulin secretion. The lipopolysaccharide molecule consists of three parts: LIPID A, core polysaccharide, and O-specific chains (O ANTIGENS). When derived from Escherichia coli, lipopolysaccharides serve as polyclonal B-cell mitogens commonly used in laboratory immunology. (From Dorland, 28th ed) Lipopolysaccharide,Lipoglycans
D008810 Mice, Inbred C57BL One of the first INBRED MOUSE STRAINS to be sequenced. This strain is commonly used as genetic background for transgenic mouse models. Refractory to many tumors, this strain is also preferred model for studying role of genetic variations in development of diseases. Mice, C57BL,Mouse, C57BL,Mouse, Inbred C57BL,C57BL Mice,C57BL Mice, Inbred,C57BL Mouse,C57BL Mouse, Inbred,Inbred C57BL Mice,Inbred C57BL Mouse
D009838 Oligodeoxyribonucleotides A group of deoxyribonucleotides (up to 12) in which the phosphate residues of each deoxyribonucleotide act as bridges in forming diester linkages between the deoxyribose moieties. Oligodeoxynucleotide,Oligodeoxyribonucleotide,Oligodeoxynucleotides
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D001402 B-Lymphocytes Lymphoid cells concerned with humoral immunity. They are short-lived cells resembling bursa-derived lymphocytes of birds in their production of immunoglobulin upon appropriate stimulation. B-Cells, Lymphocyte,B-Lymphocyte,Bursa-Dependent Lymphocytes,B Cells, Lymphocyte,B Lymphocyte,B Lymphocytes,B-Cell, Lymphocyte,Bursa Dependent Lymphocytes,Bursa-Dependent Lymphocyte,Lymphocyte B-Cell,Lymphocyte B-Cells,Lymphocyte, Bursa-Dependent,Lymphocytes, Bursa-Dependent
D015854 Up-Regulation A positive regulatory effect on physiological processes at the molecular, cellular, or systemic level. At the molecular level, the major regulatory sites include membrane receptors, genes (GENE EXPRESSION REGULATION), mRNAs (RNA, MESSENGER), and proteins. Receptor Up-Regulation,Upregulation,Up-Regulation (Physiology),Up Regulation
D051197 Toll-Like Receptor 4 A pattern recognition receptor that interacts with LYMPHOCYTE ANTIGEN 96 and LIPOPOLYSACCHARIDES. It mediates cellular responses to GRAM-NEGATIVE BACTERIA. TLR4 Receptor,Toll-4 Receptor,Receptor, TLR4,Toll 4 Receptor,Toll Like Receptor 4
D051217 Toll-Like Receptor 9 A pattern recognition receptor that binds unmethylated CPG CLUSTERS. It mediates cellular responses to bacterial pathogens by distinguishing between self and bacterial DNA. CD289 Antigen,TLR9 Protein,TLR9 Receptor,Antigen, CD289,Receptor, TLR9,Toll Like Receptor 9
D051379 Mice The common name for the genus Mus. Mice, House,Mus,Mus musculus,Mice, Laboratory,Mouse,Mouse, House,Mouse, Laboratory,Mouse, Swiss,Mus domesticus,Mus musculus domesticus,Swiss Mice,House Mice,House Mouse,Laboratory Mice,Laboratory Mouse,Mice, Swiss,Swiss Mouse,domesticus, Mus musculus
D053265 B-Cell Activation Factor Receptor A member of the tumor necrosis factor receptor superfamily that specifically binds B-CELL ACTIVATING FACTOR. It is found on B-LYMPHOCYTES and plays a role in maturation and survival of B-cells. Signaling by the activated receptor occurs through its association with TNF RECEPTOR-ASSOCIATED FACTORS. Antigens, CD268,CD268 Antigens,Tumor Necrosis Factor Receptor Superfamily, Member 13C,B Cell-Activating Factor Receptor,BAFF Receptor,BR3 B-Cell Activation Factor Receptor,CD268 Antigen,Receptor, B Cell-Activating Factor,Antigen, CD268,B Cell Activating Factor Receptor,B Cell Activation Factor Receptor,BR3 B Cell Activation Factor Receptor,Receptor, B Cell Activating Factor,Receptor, BAFF

Related Publications

Laura S Treml, and Gianluca Carlesso, and Kristen L Hoek, and Jason E Stadanlick, and Taku Kambayashi, and Richard J Bram, and Michael P Cancro, and Wasif N Khan
December 2015, Cytokine,
Laura S Treml, and Gianluca Carlesso, and Kristen L Hoek, and Jason E Stadanlick, and Taku Kambayashi, and Richard J Bram, and Michael P Cancro, and Wasif N Khan
January 2008, Immunology and cell biology,
Laura S Treml, and Gianluca Carlesso, and Kristen L Hoek, and Jason E Stadanlick, and Taku Kambayashi, and Richard J Bram, and Michael P Cancro, and Wasif N Khan
February 2021, Nature communications,
Laura S Treml, and Gianluca Carlesso, and Kristen L Hoek, and Jason E Stadanlick, and Taku Kambayashi, and Richard J Bram, and Michael P Cancro, and Wasif N Khan
November 2015, Immunological reviews,
Laura S Treml, and Gianluca Carlesso, and Kristen L Hoek, and Jason E Stadanlick, and Taku Kambayashi, and Richard J Bram, and Michael P Cancro, and Wasif N Khan
May 2008, Journal of immunology (Baltimore, Md. : 1950),
Laura S Treml, and Gianluca Carlesso, and Kristen L Hoek, and Jason E Stadanlick, and Taku Kambayashi, and Richard J Bram, and Michael P Cancro, and Wasif N Khan
January 2008, Nature immunology,
Laura S Treml, and Gianluca Carlesso, and Kristen L Hoek, and Jason E Stadanlick, and Taku Kambayashi, and Richard J Bram, and Michael P Cancro, and Wasif N Khan
January 1988, Advances in experimental medicine and biology,
Laura S Treml, and Gianluca Carlesso, and Kristen L Hoek, and Jason E Stadanlick, and Taku Kambayashi, and Richard J Bram, and Michael P Cancro, and Wasif N Khan
September 2011, The Journal of experimental medicine,
Laura S Treml, and Gianluca Carlesso, and Kristen L Hoek, and Jason E Stadanlick, and Taku Kambayashi, and Richard J Bram, and Michael P Cancro, and Wasif N Khan
May 2002, Nature reviews. Immunology,
Laura S Treml, and Gianluca Carlesso, and Kristen L Hoek, and Jason E Stadanlick, and Taku Kambayashi, and Richard J Bram, and Michael P Cancro, and Wasif N Khan
January 2005, Annual review of immunology,
Copied contents to your clipboard!